Disclosures for "Characterization of Misdiagnosed and Undiagnosed Huntington’s Disease (HD) Patients and Family Members at UCLA"
-
Ms. Shammas has received personal compensation for serving as an employee of Arrowhead Pharmaceuticals. Ms. Shammas has received personal compensation for serving as an employee of Architect Therapeutics.
-
Ms. Tobar has nothing to disclose.
-
Mr. Okine has nothing to disclose.
-
Miss Perez has nothing to disclose.
-
Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Clinical Education Alliance. Dr. Mendizabal has received research support from Huntington's Disease Society of America. Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Huntington's Disease Society of America (HDSA).